-transparent.png){kind=logo}
A double-blind, parallel, placebo-controlled study was performed to assess the efficacy of a combination drug product containing the antihistamine, triprolidine, and the sympathomimetic, pseudoephedrine, in the treatment of allergic rhinitis. Allergic rhinitis was defined on the basis of coexistent nasal congestion and an aggregate symptom complex score which exceeded a pre-established value. Pseudoephedrine and triprolidine were shown to make distinct and separate contributions to the treatment of allergic rhinitis defined in this manner.
Related Publications
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
January 1975,
La Prensa medica mexicana,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
May 1979,
Annals of allergy,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
February 2006,
Archives of otolaryngology--head & neck surgery,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
July 2006,
Expert review of clinical immunology,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
March 1995,
The Nurse practitioner,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
January 1975,
Annals of allergy,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
July 1984,
British journal of clinical pharmacology,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
March 1996,
Rhinology,
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
January 1995,
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993),
L Diamond, and
K Gerson, and
A Cato, and
K Peace, and
J G Perkins
December 1959,
The Journal of the Indiana State Medical Association,
